MSDS   | : | p-Benzoquinone,
2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-
| CAS   | : | 800-24-8 | SYNONYMS   | : | * A-139
* Aziridyl benzoquinone
* BAY A 139
* Bayer A 139
* Bayer E39 soluble
* Benzoquinone aziridine
* 2,5-Bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-2,5-cyclohexadiene-1,4-di
one
* 2,5-Bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-p-benzoquinone
* 3,6-Bis(beta-methoxyethoxy)-2,5-bis(ethylenimino)-p-benzoquinone
* 2,5-Bismethoxyethoxy-3,6-bisethyleneimino-1,4-benzoquinone
* 3,6-Bis(beta-methoxyethoxy)-2,5-bis(ethyleneimino)-p-benzoquinone
* E 39 Soluble
* NSC-17262
|
| |
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : DK3325000
CHEMICAL NAME : p-Benzoquinone,
2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-
CAS REGISTRY NUMBER : 800-24-8
BEILSTEIN REFERENCE NO. : 0320574
REFERENCE : 4-20-00-00034 (Beilstein Handbook Reference)
LAST UPDATED : 199612
DATA ITEMS CITED : 10
MOLECULAR FORMULA : C16-H22-N2-O6
MOLECULAR WEIGHT : 338.40
WISWESSER LINE NOTATION : L6V DVJ BO2O1 EO2O1 C- AT3NTJ& F- AT3NTJ
COMPOUND DESCRIPTOR : Tumorigen
Mutagen
SYNONYMS/TRADE NAMES :
* A-139
* Aziridyl benzoquinone
* BAY A 139
* Bayer A 139
* Bayer E39 soluble
* Benzoquinone aziridine
* 2,5-Bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-2,5-cyclohexadiene-1,4-di
one
* 2,5-Bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-p-benzoquinone
* 3,6-Bis(beta-methoxyethoxy)-2,5-bis(ethylenimino)-p-benzoquinone
* 2,5-Bismethoxyethoxy-3,6-bisethyleneimino-1,4-benzoquinone
* 3,6-Bis(beta-methoxyethoxy)-2,5-bis(ethyleneimino)-p-benzoquinone
* E 39 Soluble
* NSC-17262
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 250 ug/kg
TOXIC EFFECTS :
Gastrointestinal - other changes
Blood - leukopenia
Blood - thrombocytopenia
REFERENCE :
CCSUBJ Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5,
1964-75. For publisher information, see CTRRDO. Volume(issue)/page/year:
2,203,1965
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Primate - monkey
DOSE/DURATION : 500 ug/kg
TOXIC EFFECTS :
Gastrointestinal - other changes
Blood - leukopenia
Blood - other changes
REFERENCE :
CCSUBJ Cancer Chemotherapy Reports, Part 2. (Washington, DC) V.1-5,
1964-75. For publisher information, see CTRRDO. Volume(issue)/page/year:
2,203,1965
** TUMORIGENIC DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 4 mg/kg/4W
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Lungs, Thorax, or Respiration - tumors
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
36,915,1966
** MUTATION DATA **
TYPE OF TEST : Phage inhibition capacity
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 200 mg/L
REFERENCE :
ARMKA7 Archiv fuer Mikrobiologie. (Berlin, Fed. Rep. Ger.) V.1-94,
1930-73. For publisher information, see AMICCW. Volume(issue)/page/year:
51,9,1965
TYPE OF TEST : Dominant lethal test
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Insect - Drosophila melanogaster
DOSE/DURATION : 1 umol/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 14,250,1972
TYPE OF TEST : Cytogenetic analysis
TEST SYSTEM : Human Leukocyte
DOSE/DURATION : 500 nmol/L
REFERENCE :
EXPEAM Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel,
Switzerland) V.1- 1945- Volume(issue)/page/year: 29,1154,1973
*** REVIEWS ***
IARC Cancer Review:Animal Limited Evidence
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 9,51,1975
IARC Cancer Review:Human No Adequate Data
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 9,51,1975
IARC Cancer Review:Group 3
IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49
Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year:
7,56,1987
*** STATUS IN U.S. ***
EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Benzothiazole,5-methoxy-2-(beta-(1-pyrrolidinyl)-p-phenetidino)-
| 38519-94-7 |
Benzothiazole, 2-methyl-
| 120-75-2 |
Benzothiazole, 2-(methylamino)-
| 16954-69-1 |
Benzothiazole, 6-((p-(methylamino)phenyl)azo)-
| 16954-69-1 |
Benzothiazole,2-(2-((1-methylethyl)thio)-4-thiazolyl)-
| 67723-95-9 |
Benzothiazole, 2-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-
| 43193-11-9 |
Benzothiazole, 2-(3-methyl-1H-pyrazol-5-yl)-
| 43193-11-9 |
Benzothiazole, 2-(2-(methylthio)-4-thiazolyl)-
| 67723-92-6 |
Benzothiazole, 2-(morpholinothio)-
| 102-77-2 |
p-Benzoquinone,2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-
| 800-24-8 |
p-Benzoquinone, 2,6-dimethoxy-3-(hydroxymethyl)-,acetate (ester)
| 40870-53-9 |
Benzothiazole, 2-(4-morpholinyldithio)-
| 95-32-9 |
Benzothiazole, 6-nitro-2-(p-nitrobenzoylamino)-
| 64036-74-4 |
Benzothiazole, 2-(2-nitrophenyl)-
| 6269-45-0 |
Benzothiazole, 2-pentylthio-
| 73713-86-7 |
Benzothiazole, 2-phenyl-
| 883-93-2 |
Benzothiazole, 6-((p-piperidinophenyl)azo)-
| 84713-38-2 |
Benzothiazole, 2-(piperidinothio)-
| 26773-65-9 |
3(2H)-Benzothiazolepropanamide,2-imino-6-(trifluoromethoxy)-
| 130997-38-5 |
3(2H)-Benzothiazolepropanenitrile,2-imino-6-(trifluoromethoxy)-, ethanedioate (1:1)
| 130997-37-4 |
3-Benzothiazolepropanesulfonic acid,2-(4-(3-ethyl-4-oxo-2-thioxo-5-thiazolidinylidene)-2-butenylidene)-
| 64285-53-6 |
p-Benzoquinone,2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-
| 303-97-9 |
3(2H)-Benzothiazolepropanoic acid,2-(4-(3-(2-carboxyethyl)-4-oxo-2-thioxo-5-thiazolidinylidene)-2-butenylidene)-6-methyl-
| 62883-67-4 |
5-Benzothiazolepropionic acid, 2-phenyl-
| 52321-54-7 |
Benzothiazole, 2-(2-(propylthio)-4-thiazolyl)-
| 67723-94-8 |
Benzothiazole, 2-(2-pyridyl)-
| 716-80-3 |
Benzothiazole, 6-((p-(1-pyrrolidinyl)phenyl)azo)-
| 716-80-3 |
2-Benzothiazolesulfenamide
| 2801-21-0 |
2-Benzothiazolesulfenamide, N-tert-butyl-
| 95-31-8 |
2-Benzothiazolesulfenamide, N-cyclohexyl-
| 95-33-0 |
2-Benzothiazolesulfenamide, N,N-dicyclohexyl-
| 4979-32-2 |
2-Benzothiazolesulfenamide, N,N-diisopropyl-
| 95-29-4 |
p-Benzoquinone, 2,3-dimethyl-
| 526-86-3 |
2-Benzothiazolesulfonamide, 6-ethoxy-
| 452-35-7 |
Benzothiazolesulfonamide, N-(1-methylethyl)-
| 63904-87-0 |
7-Benzothiazolesulfonic acid,2-(p-aminophenyl)-6-methyl-
| 130-17-6 |
7-Benzothiazolesulfonic acid,2,2'-(1-triazene-1,3-diyldi-4,1-phenylene)bis(6-methyl-, disodium salt
| 1829-00-1 |
Benzothiazole, 4,5,6,7-tetrahydro-2-amino-
| 2933-29-1 |
Benzothiazole, 4,5,6,7-tetrahydro-,1,2-ethanedisulfonate (2:1)
| 31784-85-7 |
Benzothiazole, 4,5,6,7-tetrahydro-6-(methylamino)-
| 70590-58-8 |
Benzothiazole,4,5,6,7-tetrahydro-2-(2-(5-nitrofuryl)vinyl)-
| 30311-48-9 |
Benzothiazole,4,5,6,7-tetrahydro-2-(2-(5-nitrofuryl)vinyl)-,3-oxide
| 40019-78-1 |
2-Benzothiazolethiol
| 149-30-4 |
p-Benzoquinone, 2,5-dimethyl-
| 137-18-8 |
2-Benzothiazolethiol, 6-amino-
| 7442-07-1 |
2-Benzothiazolethiol, 5-chloro-
| 5331-91-9 |
2-Benzothiazolethiol, 6-ethoxy-
| 120-53-6 |
Benzothiazolethiol, 2-ethoxycarbonylmethyl-
| 64036-42-6 |
Benzothiazolethiol, 2-methyl-
| 64036-43-7 |
2-Benzothiazolethiol, 6-nitro-
| 4845-58-3 |
|
|